SCHEMBL6824040

SCHEMBL6824040

CC(C)=C1Oc2cccc(OCCCC(=O)N3CCC(NCc4ccccc4)CC3)c2C1=O

nearest known ligand 0.42

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
ALDH1A1 P00352 5/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
HPGD P15428 1/20 0.39
TSHR P16473 3/20 0.38
DRD4 P21917 1/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
LTA4H P09960 3/20 0.38
FABP6 P51161 1/20 0.37
KDM4E B2RXH2 1/20 0.37
EBP Q15125 1/20 0.36
DHCR7 Q9UBM7 1/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6824647 0.93 KMT2A (0.42) NPC1RAB9AALDH1A1HPGDTSHR
SCHEMBL6823289 0.89 ALDH1A1 (0.37) NPC1RAB9AALDH1A1SMN1; SMN2HPGD
SCHEMBL6820550 0.83 NPC1 (0.42) NPC1RAB9AALDH1A1SMN1; SMN2HPGD
SCHEMBL6826721 0.81 MEN1 (0.45) NPC1RAB9AALDH1A1SMN1; SMN2HPGD
SCHEMBL6820561 0.80 UTS2R (0.45) MEN1KMT2A
SCHEMBL6462625 0.77 SIGMAR1 (0.52)
SCHEMBL6823437 0.76 TSHR (0.41) ALDH1A1TSHRMEN1KMT2A
SCHEMBL6458570 0.73 POLB (0.49) LTA4H
SCHEMBL6824170 0.72 LMNA (0.47) TSHRMEN1KMT2A
SCHEMBL6422310 0.70 MTNR1A (0.36) ALDH1A1SMN1; SMN2TSHRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004076444-A2 NOVEL HYDROXYCOUMARANONE DERIVATIVES AS ANTITUMOR AND ANTIMETASTATIC F. HOFFMANN-LA ROCHE AG (CH) 2004-09-10 WO claimed
WO-2004076444-A2 NOVEL HYDROXYCOUMARANONE DERIVATIVES AS ANTITUMOR AND ANTIMETASTATIC F. HOFFMANN-LA ROCHE AG (CH) 2004-09-10 WO disclosed